AMB FUBINACA (also known as FUB-AMB and MMB-FUBINACA) is an indazole based synthetic
cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer
drug.It was originally developed by Pfizer which described the compound in a patent in 2009,
but was later abandoned and never tested on humans.
FUB-AMB (AMB-FUBINACA) Effects similar to: APINACA and 5F-APINACA, Cannabis
AMB-FUBINACA,FUB-MAB,MMB-FUBINACA CAS 1715016-76-4
Systematic (IUPAC) name
Molecular mass 383.41 g/mol
Despite the lack of information on how a chemical substance like this impacts human subjects, many individuals have started to buy FUB-AMB for use as a recreational designer drug. The purpose of this in many users is because they hope to achieve euphoric experiences similar or greater than those they might achieve with more commonly obtained prescription medications or over the counter substances. Some might also use this type of chemical as a recreational drug in the hopes of achieving these results without the negative side effects that can also be brought on by those more common medications.
Designer drugs like FUB-AMB typically yield results that offer the user feelings of euphoria, increased levels of emotional connection with those around them, prolonged periods of wakefulness, and even decreases in appetite. With stimulant drugs like this, many users find that they have heightened levels of philosophical thinking and more abstract ideas than they normally would.